Liposome-encapsulated doxorubicin plus cyclophosphamide followed by trastuzumab plus docetaxel as neoadjuvant therapy for HER2-positive breast cancer (BC): A multicenter single-arm phase II study

被引：0

作者：

Saracchini, Silvana

Foltran, Luisa

Sulfaro, Sandro

Tuccia, Fausto

Del Conte, Alessandro

Bertolla, Manuella

Bassini, Anna

Micheli, Elvia

Manente, Stefania

Gusso, Giuseppina

Baresic, Tania

Tumoio, Salvatore

机构：

[1] S Maria Degli Angeli Hosp, Pordenone, Italy

[2] S Maria degli Angell Pordenone, Pordenone, Italy

[3] Osped Civile S Martino, Belluno, Italy

[4] Santa Maria degli Angell Hosp, Pordenone, Italy

[5] Ctr Riferimento Oncol, Aviano, Italy

[6] S Maria degli Angell Hosp, Pordenone, Italy

[7] S Maria degli Angell Hosp, Dept Med Oncol, Pordenone, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

641

引用

页数：1